ISSN 1004-4140
    CN 11-3017/P

    胸部CT扫描中甲状腺屏蔽策略对辐射剂量和图像质量的影响

    Effects of Thyroid Shielding Strategies on Radiation Dose and Image Quality in Chest CT Scan

    • 摘要: 目的:探讨自动调制技术应用下,不同甲状腺屏蔽策略对胸部CT辐射剂量、人工智能肺结节识别准确度及图像质量的影响。方法:使用Lungman ph-1胸部模体、CIRS 711-HN头部模体和两个椭圆型自制模体构建实验模型。设置三种甲状腺屏蔽方式(1组:无屏蔽;2组:定位像前屏蔽;3组:定位像后屏蔽)。每种方式下,对实验模型重复10次胸部CT扫描。扫描时采用自动管电压和自动管电流调制技术,记录扫描参数及总辐射剂量;通过热释光剂量计测量眼晶状体、甲状腺、乳腺和腹部器官剂量。采用人工智能辅助诊断系统评价9种特征结节(CT值100/−630/−800 Hu,直径5/8/10 mm)的识别准确度;结合对比度噪声比与Likert五级量表完成图像质量主客观评价。结果:①定位像前使用甲状腺屏蔽(2组),CTDIvol(5.054 ± 0.276 mGy)和DLP(186.960 ± 10.991 mGy·cm)最高,与1组和3组均具有统计学差异,P < 0.001。②定位像后使用甲状腺屏蔽(3组),甲状腺、眼晶状体、乳腺和腹部表面剂量均为最低,其中甲状腺表面剂量(3.009 ± 0.626 mGy)较1组(11.327 ± 1.375 mGy)降低约73%。甲状腺和腹部表面剂量均显著高于屏蔽外剂量,P < 0.001。③人工智能辅助诊断系统对结节识别异常均为尺寸偏差,−800 Hu/5 mm结节均未被识别。仅−630 Hu/5 mm结节三组识别有差异,校正后无统计学差异(均P > 0.017)。④三种屏蔽方式所有层面CNR均无统计学差异(P > 0.05)。⑤主观评分一致性较高,Kappa = 0.706。三种屏蔽方式图像主观评分存在统计学差异(P < 0.05),其中无屏蔽组(1组)主观评分最高且与2组存在统计学差异(P = 0.005)。结论:胸部CT甲状腺屏蔽可降低外散射辐射,定位像前屏蔽会增加CTDIvol,定位像后屏蔽对图像质量及AI识别有轻微影响,临床需谨慎选择实施。

       

      Abstract: Objective: To investigate the effects of different thyroid-shielding strategies on radiation dose, artificial intelligence (AI)-based lung nodule detection accuracy, and image quality in chest CT using automatic modulation technology. Methods: An experimental model was constructed using a Lungman PH-1 chest phantom, a CIRS 711-HN head phantom, and two custom-made elliptical phantoms. Three thyroid-shielding protocols were established: Group 1 (no shielding), Group 2 (shielding before scout scan), and Group 3 (shielding after scout scan). Ten chest CT scans were performed for each group. Automatic tube voltage and tube current modulation technologies were utilized, and scanning parameters and total radiation doses were recorded. Doses to the lens of the eye, thyroid, breast, and abdominal organs were measured using thermoluminescent dosimeters (TLDs). An AI-assisted diagnosis system was used to evaluate the detection accuracy of nine types of characteristic nodules (CT values: 100/−630/−800 Hu; diameters: 5/8/10 mm). Subjective and objective image quality evaluations were performed using the contrast-to-noise ratio (CNR) and a 5-point Likert scale. Results: (1) Thyroid shielding before the scout scan (Group 2) resulted in the highest CTDIvol 5.054 ± 0.276 mGy) and DLP (186.960 ± 10.991 mGy·cm), showing significant statistical differences compared to Groups 1 and 3 (all P < 0.001). (2) Thyroid shielding after the scout scan (Group 3) resulted in the lowest surface doses to the thyroid, lens, breast, and abdomen. Specifically, the thyroid surface dose (3.009 ± 0.626 mGy) was reduced by approximately 73% compared to Group 1 (11.327 ± 1.375 mGy). Surface doses for the thyroid and abdomen were significantly higher than doses measured outside the shielding (P < 0.001). (3) Abnormalities in AI-based nodule recognition were limited to size deviations; notably, −800 Hu/5 mm nodules were not detected in any group. Significant differences in recognition were only observed for −630 Hu/5 mm nodules among the three groups, which disappeared after correction (all P > 0.017). (4) There were no significant differences in CNR across all layers among the three shielding protocols (P > 0.05). (5) Subjective scores showed high consistency (Kappa = 0.706). Significant differences in subjective scores existed among the three groups (P < 0.05), with Group 1 achieving the highest score and showing a significant difference compared to Group 2 (P = 0.005). Conclusion: Thyroid shielding in chest CT can effectively reduce external scatter radiation. However, shielding before the scout scan increases CTDIvol, while shielding after the scout scan has a slight impact on image quality and AI recognition. Therefore, clinical implementation requires careful selection.

       

    /

    返回文章
    返回